Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Núria, Eritja"'
Autor:
Anna Ruiz-Mitjana, Raúl Navaridas, Maria Vidal-Sabanés, Aida Perramon-Güell, Andree Yeramian, Isidre Felip, Núria Eritja, Joaquim Egea, Mario Encinas, Xavier Matias-Guiu, Xavier Dolcet
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-19 (2022)
Abstract The extracellular matrix and the correct establishment of epithelial cell polarity plays a critical role in epithelial cell homeostasis and cell polarity. In addition, loss of tissue structure is a hallmark of carcinogenesis. In this study,
Externí odkaz:
https://doaj.org/article/f38b438a650b4c409f3101a0c6d92387
Autor:
Cristina Megino‐Luque, Pol Sisó, Natalia Mota‐Martorell, Raúl Navaridas, Inés de laRosa, Izaskun Urdanibia, Manel Albertí‐Valls, Maria Santacana, Miquel Pinyol, Núria Bonifaci, Anna Macià, David Llobet‐Navas, Sònia Gatius, Xavier Matias‐Guiu, Núria Eritja
Publikováno v:
Molecular Oncology, Vol 16, Iss 11, Pp 2235-2259 (2022)
AT‐rich interactive domain‐containing protein 1A (ARID1A) loss‐of‐function mutation accompanied by a loss of ARID1A protein expression is frequently observed in endometrial carcinomas. However, the molecular mechanisms linking these genetic c
Externí odkaz:
https://doaj.org/article/88829f0c96d5428fb487eeec1a5e9881
Autor:
Giorgia Sonzini, Sofia Granados-Aparici, Sabina Sanegre, Angel Diaz-Lagares, Juan Diaz-Martin, Carlos de Andrea, Núria Eritja, Aida Bao-Caamano, Nicolás Costa-Fraga, David García-Ros, Carmen Salguero-Aranda, Ben Davidson, Rafael López-López, Ignacio Melero, Samuel Navarro, Santiago Ramon y Cajal, Enrique de Alava, Xavier Matias-Guiu, Rosa Noguera
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
The incidence of new cancer cases is expected to increase significantly in the future, posing a worldwide problem. In this regard, precision oncology and its diagnostic tools are essential for developing personalized cancer treatments. Digital pathol
Externí odkaz:
https://doaj.org/article/1debe2f1f3eb466fb9188e4c9d95f9d3
Autor:
Sabina Sanegre, Núria Eritja, Carlos de Andrea, Juan Diaz-Martin, Ángel Diaz-Lagares, María Amalia Jácome, Carmen Salguero-Aranda, David García Ros, Ben Davidson, Rafel Lopez, Ignacio Melero, Samuel Navarro, Santiago Ramon y Cajal, Enrique de Alava, Xavier Matias-Guiu, Rosa Noguera
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
The invasive tumor front (the tumor–host interface) is vitally important in malignant cell progression and metastasis. Tumor cell interactions with resident and infiltrating host cells and with the surrounding extracellular matrix and secreted fact
Externí odkaz:
https://doaj.org/article/743805c8e0f34b5ba6114838c5cfc6a8
AT-rich interactive domain-containing protein 1A (ARID1A) loss-of-function mutation accompanied by a loss of ARID1A protein expression is frequently observed in endometrial carcinomas (EC). However, the mechanisms underlying this loss of ARID1A invol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed21950d8e9117ba02d7f22bde8c00dc
https://doi.org/10.1101/2022.12.14.520528
https://doi.org/10.1101/2022.12.14.520528
Autor:
Sònia Gatius, Mariona Jove, Cristina Megino-Luque, Manel Albertí-Valls, Andree Yeramian, Nuria Bonifaci, Miquel Piñol, Maria Santacana, Irene Pradas, David Llobet-Navas, Reinald Pamplona, Xavier Matías-Guiu, Núria Eritja
Publikováno v:
Cancers; Volume 14; Issue 12; Pages: 2842
Metabolomic profiling analysis has the potential to highlight new molecules and cellular pathways that may serve as potential therapeutic targets for disease treatment. In this study, we used an LC-MS/MS platform to define, for the first time, the sp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c203d989e3dcc86de3239e0e4085fc0
Autor:
Cristina Mirantes, Núria Eritja, Maria Alba Dosil, Maria Santacana, Judit Pallares, Sónia Gatius, Laura Bergadà, Oscar Maiques, Xavier Matias-Guiu, Xavier Dolcet
Publikováno v:
Disease Models & Mechanisms, Vol 6, Iss 3, Pp 710-720 (2013)
SUMMARY PTEN is one of the most frequently mutated tumor suppressor genes in human cancers. The role of PTEN in carcinogenesis has been validated by knockout mouse models. PTEN heterozygous mice develop neoplasms in multiple organs. Unfortunately, th
Externí odkaz:
https://doaj.org/article/ef731cf3c44f4c4d94d4002ea39b22b3
Author response for 'ARID1A ‐deficient cells require HDAC6 for progression of endometrial carcinoma'
Autor:
null Cristina Megino‐Luque, null Pol Sisó, null Natalia Mota‐Martorell, null Raúl Navaridas, null Inés de la Rosa, null Izaskun Urdanibia, null Manel Albertí‐Valls, null Maria Santacana, null Miquel Pinyol, null Núria Bonifaci, null Anna Macià, null David Llobet‐Navas, null Sònia Gatius, null Xavier Matias‐Guiu, null Núria Eritja
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f30489d8efe854fdcf5243a3ed1c10dd
https://doi.org/10.1002/1878-0261.13193/v2/response1
https://doi.org/10.1002/1878-0261.13193/v2/response1
Autor:
Carla, Barceló, Pol, Sisó, Oscar, Maiques, Sandra, García-Mulero, Rebeca, Sanz-Pamplona, Raúl, Navaridas, Cristina, Megino, Isidre, Felip, Izaskun, Urdanibia, Núria, Eritja, Xavier, Soria, Josep M, Piulats, Rosa M, Penin, Xavier, Dolcet, Xavier, Matías-Guiu, Rosa M, Martí, Anna, Macià
Publikováno v:
The Journal of investigative dermatology. 140(6)
Melanoma is a malignant neoplasia that is highly resistant to chemotherapy and radiotherapy and is associated with poor prognosis in advanced stage. Targeting melanoma that harbors the common BRAF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::90b4c86f4624726d541e2333c7814521
https://pubmed.ncbi.nlm.nih.gov/31877318
https://pubmed.ncbi.nlm.nih.gov/31877318
Autor:
Maria A, Dosil, Raúl, Navaridas, Cristina, Mirantes, Jordi, Tarragona, Núria, Eritja, Isidre, Felip, Izaskun, Urdanibia, Cristina, Megino, Mónica, Domingo, Maria, Santacana, Sònia, Gatius, Carme, Piñol, Carla, Barceló, Oscar, Maiques, Anna, Macià, Ana, Velasco, Marta, Vaquero, Xavier, Matias-Guiu, Xavier, Dolcet
Publikováno v:
The Journal of pathology. 247(1)
Many human cancers present Phosphatase and tensin homolog (PTEN) deficiency and between 20 and 30% of colorectal tumors show PTEN loss. The transcription factor, E2 promoter binding factor 1 (E2F-1), exhibits tumor promoter or suppressive functions d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::87ffa2484fcdbed1ce1089b278b9586f
https://pubmed.ncbi.nlm.nih.gov/30206933
https://pubmed.ncbi.nlm.nih.gov/30206933